Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP2 | P50579 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.37 |
| ▸ | TNF | P01375 | 2/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.36 |
| ▸ | PLK4 | O00444 | 1/20 | 0.35 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.35 |
| ▸ | PIM1 | P11309 | 1/20 | 0.35 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.35 |
| ▸ | LTK | P29376 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6269850 | 0.82 | CYP11B2 (0.43) | CYP19A1CES1CYP11B2MIFPKM | |
| SCHEMBL13262088 | 0.79 | CYP11B2 (0.45) | MAOAMAPTHPGDCYP19A1BCHE | |
| SCHEMBL17264310 | 0.78 | SIGMAR1 (0.41) | MAOAMAOB | |
| SCHEMBL17264313 | 0.76 | TDP1 (0.33) | METAP2KDM4EMAPTSMN1; SMN2LMNA | |
| SCHEMBL8035058 | 0.75 | KDM4E (0.32) | METAP2KDM4ENPC1MAPTRAB9A | |
| SCHEMBL30011414 | 0.75 | METAP2 (0.46) | METAP2MAOAKDM4ENPC1MAPT | |
| SCHEMBL51294 | 0.75 | METAP2 (0.46) | METAP2MAOAKDM4ENPC1MAPT | |
| SCHEMBL29360004 | 0.75 | METAP2 (0.46) | METAP2MAOAKDM4ENPC1MAPT | |
| SCHEMBL27174135 | 0.75 | METAP2 (0.46) | METAP2MAOAKDM4ENPC1MAPT | |
| SCHEMBL2485732 | 0.74 | METAP2 (0.42) | METAP2MAOAKDM4ENPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 499 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111987230-B | Organic light emitting device and apparatus including the same | 三星显示有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-115850256-B | Diazafluorene compound, material for organic electroluminescent device and organic electroluminescent device | 东莞伏安光电科技有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-118561836-A | Heterocyclic derivative and organic electroluminescent device comprising the same | 海宁奕诺炜特科技有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-118440075-A | Organic electroluminescent compound and organic electroluminescent element comprising same | 海宁奕诺炜特科技有限公司 | 2024-08-06 | — | — | CN | claimed |
| WO-2024108789-A1 | DIAZAFLUORENE COMPOUND, MATERIAL FOR ORGANIC LIGHT-EMITTING DEVICE, AND ORGANIC LIGHT-EMITTING DEVICE | 东莞伏安光电科技有限公司 | 2024-05-30 | — | — | WO | claimed |
| US-20230231508-A1 | WINDOWS WITH POWER GENERATION FROM TRANSPARENT SOLAR ENERGY HARVESTING DEVICES COMPRISING WAVELENGTH-SPECIFIC ABSORBERS | ANDLUCA TECHNOLOGIES INC. | 2023-07-20 | — | — | US | claimed |
| CN-113150243-B | Dynamic self-healing antirust epoxy resin and preparation method thereof | 中国船舶重工集团公司第七二五研究所 | 2023-06-23 | — | — | CN | claimed |
| CN-115850256-A | Diazafluorene compound, material for organic electroluminescent device and organic electroluminescent device | 东莞伏安光电科技有限公司 | 2023-03-28 | — | — | CN | claimed |
| US-20220340571-A1 | LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-10-27 | — | — | US | claimed |
| US-11462703-B2 | Organic light-emitting device and apparatus including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-10-04 | — | — | US | claimed |
| EP-1868600-A1 | SPIROCYCLIC CYCLOHEXANE DERIVATIVES FOR USE IN THE TREATMENT OF SUBSTANCE DEPENDENCY | Grünenthal GmbH (DE) | 2007-12-26 | — | — | EP | claimed |
| WO-2006108565-A1 | SPIROCYCLIC CYCLOHEXANE DERIVATIVES FOR USE IN THE TREATMENT OF SUBSTANCE DEPENDENCY | Grünenthal GmbH (DE) | 2006-10-19 | — | — | WO | claimed |
| US-20040028612-A1 | Optical determination of glucose utilizing boronic acid adducts | REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE | 2004-02-12 | — | — | US | claimed |
| US-6653141-B2 | In vitro detection of polyhydroxyl-substituted organic molecules; obtain sample, incubate in fluorescent dye exposure to excitation light detect and measure signal | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2003-11-25 | — | — | US | claimed |
| US-6627177-B2 | Obtaining flurorophore dye which is compatible with the analyte solution; combining withboronic acid-containing quencher molecule; contacting with excitation light source coupled with a detector; producing signal; quantification | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2003-09-30 | — | — | US | claimed |
| EP-1340076-A2 | OPTICAL DETERMINATION OF GLUCOSE UTILIZING BORONIC ACID ADDUCTS | The Regents of the University of California (US) | 2003-09-03 | — | — | EP | claimed |
| WO-2002046752-A9 | OPTICAL DETERMINATION OF GLUCOSE UTILIZING BORONIC ACID ADDUCTS | UNIV CALIFORNIA (US) | 2002-08-29 | — | — | WO | claimed |
| US-20020106326-A1 | Polyhydroxyl-substituted organic molecule sensing optical in vivo method utilizing a boronic acid adduct and the device thereof | CALIFORNIA, UNIVERSITY OF THE REGENTS OF THE | 2002-08-08 | — | — | US | claimed |
| US-20020106810-A1 | Polyhydroxyl-substituted organic molecule sensing optical in vitro method utilizing a boronic acid adduct and the device thereof | REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE | 2002-08-08 | — | — | US | claimed |
| WO-2002046752-A2 | OPTICAL DETERMINATION OF GLUCOSE UTILIZING BORONIC ACID ADDUCTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2002-06-13 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220340571-A1 | LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME | CLIC1, CLCN2, CYBA | METAP2 3188/4885MAOA 3216/4885KDM4E 3608/4885 |
| US-20040028612-A1 | Optical determination of glucose utilizing boronic acid adducts | NISCH, BLVRB, FOSB | METAP2 4442/4885MAOA 1128/4885KDM4E 2992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.